Refusing Treatment-Reference-Cited by-同舟云学术

Refusing Treatment

Published:2013-04-23 Issue:5 Volume:18 Page:634-636
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Frenkel Moshe¹²³

Affiliation:

1. Department of Family Medicine, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA

2. Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3. Integrative Oncology Service, Institute of Oncology, Meir Medical Center, Kfar Saba, Israel

Abstract

The number of patients that decline conventional cancer treatment is substantial enough to warrant close attention. Effective patient-doctor communication is crucial in addressing this challenge.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2012-0436

Reference25 articles.

1. Alternative therapy used as primary treatment for breast cancer negatively impacts outcomes;Han;Ann Surg Oncol,2011

2. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy;Li;Ann Surg,2000

3. Declining conventional cancer treatment and using complementary and alternative medicine: A problem or a challenge?;Verhoef;Curr Oncol,2008

4. Cancer patients who refuse treatment;Huchcroft;Cancer Causes Control,1993

5. Characteristics of older newly diagnosed cancer patients refusing cancer treatments;Puts;Support Care Cancer,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of patient, hospital, and operative characteristics relative to social determinants of health: Compliance with National Comprehensive Cancer Network guidelines for colon cancer;Journal of Gastrointestinal Surgery;2024-09

2. Case Report: The role of Panchagavya and Panchakarma treatment in the management of radiotherapy and chemotherapy side effects in infiltrative ductal carcinoma;F1000Research;2024-04-08

3. Medical aid in dying to avoid late‐stage dementia;Journal of the American Geriatrics Society;2024-02-05

4. Combined Role of Interleukin-15 Stimulated Natural Killer Cell-Derived Extracellular Vesicles and Carboplatin in Osimertinib-Resistant H1975 Lung Cancer Cells with EGFR Mutations;Pharmaceutics;2024-01-08

5. Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk;Cancers;2024-01-05